Recall
FDAHealthDecember 19, 2024

Hikma Injectables USA Inc — ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compo

⚠️ Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 19, 2024

Nationwide in the USA

What's affected?

Product
ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25
Lot code
242560008D

Additional details

Lot number: 242560008D, Use by Date 01/15/2025; 242970002D, Use by Date 02/25/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 1,800 syringes.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.